Deep mutational scanning for therapeutic antibody engineering.
Sign Up to like & getrecommendations! Published in 2021 at "Trends in pharmacological sciences"
DOI: 10.1016/j.tips.2021.11.010
Abstract: The biophysical and functional properties of monoclonal antibody (mAb) drug candidates are often improved by protein engineering methods to increase the probability of clinical efficacy. One emerging method is deep mutational scanning (DMS) which combines… read more here.
Keywords: scanning therapeutic; engineering; antibody; mutational scanning ... See more keywords